CD276 and melanoma: Melanoma and several other solid tumors are known to express B7-H3, which may have an inhibitory effect on NK cell activity [192,193] and has grown to be a popular target for numerous immunotherapies, including both CAR-T cells and CAR-NK cells [161,194,195,196,197,198,199].